NCT06442137 - A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2024

Primary Completion Date

November 7, 2024

Study Completion Date

January 2, 2025

Conditions

Hepatic SteatosisSymptoms and Signs

Interventions

DRUG

Chazhu Xiaozhi decoction

Below is the composition of Chazhu Xiaozhi decoction: Camellia Sinensis Radix 15g, Atractylodis Rhizoma 15g, Herba Gynostemmatis Pentaphylli 15g, Ilicis Cornutae Folium 15g, Alismatis Rhizoma 9g, Nelumbinis Folium 6g, Crataegi Fructus 6g, Polygoni Orientalis Fructus 3g.

DRUG

Control placebo

The control placebo is a ten-fold dilution of the Chazhu Xiaozhi decoction, supplemented with colorants and bittering agents to mimic the appearance and color of the treatment drug.

Trial Locations (1)

200071

Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai

All Listed Sponsors

lead

Shanghai Municipal Hospital of Traditional Chinese Medicine

OTHER